Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement

Cardiovascular Revascularization Medicine

Volumn 12, Issue 3, 2011, Pages 184-186

  Rafiq, Isma ^a   Parthasarathy, Hari ^a   Tremlett, Catherine ^b   Freeman, Leisa J ^a   Mullin, Michael ^c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b NORWICH UNIVERSITY   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Aortic stenosis; Infective endocarditis; Percutaneous aortic valve replacement

Indexed keywords

AMOXICILLIN; AZATHIOPRINE; C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; STEROID;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BACTERIAL ENDOCARDITIS; BARE METAL STENT; BEDTIME DOSAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFECTION RISK; LOW DRUG DOSE; MORAXELLA; NONHUMAN; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; THORACOTOMY; THORAX PAIN; TRANSCATHETER AORTIC VALVE IMPLANTATION; UPPER RESPIRATORY TRACT INFECTION; VEIN OCCLUSION;

ANTI-BACTERIAL AGENTS; AORTIC VALVE STENOSIS; AZATHIOPRINE; ENDOCARDITIS, BACTERIAL; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MORAXELLA; MORAXELLACEAE INFECTIONS; MYASTHENIA GRAVIS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79957811061     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.03.082     Document Type: Article

References (8)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron c, Bauer F Percutaneous transcatheter transplantation of an aortic valve prosthesis for calcified aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
2. Durack DT, Lukes AS, Bright DK New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96(3):200-209.
3. Morris CD, Reller MD, Menashe VD Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 1998, 279:599-603.
4. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007, 116(7):755-763.
5. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007 3, 50(1):69-76.
6. Silberfarb PM, Lawe JE Endocarditis M liquefaciens. Arch Intern Med 1968, 122:512-513.
7. Bechard DL, Lefrock JL, Tilloston JR Endocarditis caused by Moraxella nonliquefaciens. South Med J. 1979, 72:1485-1486.
8. Maayan H, et al. Infective endocarditis due to Moraxella lacunata: Report of 4 patients and review of published cases of Moraxella endocarditis. Scand J Infect Dis 2005, 36:878.